{{Rsnum
|rsid=738722
|Gene=CHEK2
|Chromosome=22
|position=28734024
|Orientation=plus
|GMAF=0.32
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=CHEK2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 48.7 | 38.1 | 13.3
| HCB | 54.0 | 40.1 | 5.8
| JPT | 67.3 | 30.1 | 2.7
| YRI | 34.7 | 43.5 | 21.8
| ASW | 26.3 | 50.9 | 22.8
| CHB | 54.0 | 40.1 | 5.8
| CHD | 54.1 | 38.5 | 7.3
| GIH | 61.4 | 32.7 | 5.9
| LWK | 47.3 | 44.5 | 8.2
| MEX | 50.0 | 39.7 | 10.3
| MKK | 45.5 | 44.2 | 10.3
| TSI | 58.8 | 34.3 | 6.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20729852
|Trait=None
|Title=A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma
|RiskAllele=T
|Pval=1E-8
|OR=1.30
|ORtxt=[1.19-1.43]
|OA=1
}}

{{PMID Auto
|PMID=22201027
|Title=Variant allele of CHEK2 is associated with a decreased risk of esophageal cancer lymph node metastasis in a Chinese population
}}

{{PMID Auto
|PMID=21553226
|Title=Increased risk of advanced prostate cancer associated with MnSOD Ala-9-Val gene polymorphism.
}}

{{PMID Auto
|PMID=17132159
|Title=Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study.
|OA=1
}}

{{PMID Auto
|PMID=17428325
|Title=Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}